Lloyd-Smith Malcolm
SEC CIK 1557146 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NBIX | NEUROCRINE BIOSCIENCES INC | Chief Regulatory Off | 30.2K | — | $5.88M | 6 | 2021-07-27 | 2023-02-06 |
Most active insiders at NBIX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | GORMAN KEVIN CHARLES | Dir | — | $37.82M |
| 2 | Cooke Julie | CHRO | — | $5.77M |
| 3 | Gano Kyle | CEO, Dir | — | $4.87M |
| 4 | Lippoldt Darin | CLO | — | $4.20M |
| 5 | SHERWIN STEPHEN A | Dir | — | $4.13M |
| 6 | Delaet Ingrid | Chief Regulatory Off | — | $3.75M |
| 7 | Onyia Jude | CSO | — | $3.47M |
| 8 | RASTETTER WILLIAM H | Dir | — | $2.73M |
| 9 | POPS RICHARD F | Dir | — | $2.36M |
| 10 | LYONS GARY A | Dir | — | $2.29M |
Lloyd-Smith Malcolm made no open-market trades at NBIX in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-02-08 | 2023-02-06+ | NBIX | NEUROCRINE BIOSCIENCES INC | Lloyd-Smith Malcolm | Chief Integration Off | S - Sale | $102.64 | -15.3K | 30.2K | -34% | -$1.57M |
| 2023-02-02 | 2023-01-31 | NBIX | NEUROCRINE BIOSCIENCES INC | Lloyd-Smith Malcolm | Chief Integration Off | S - Sale | $110.02 | -1,666 | 28.6K | -6% | -$183.3K | |
| DM | 2022-08-16 | 2022-08-12+ | NBIX | NEUROCRINE BIOSCIENCES INC | Lloyd-Smith Malcolm | Chief Regulatory Off | M - OptEx | $38.70 | +29.6K | 26.9K | New | +$1.14M |
| D | 2022-08-16 | 2022-08-12 | NBIX | NEUROCRINE BIOSCIENCES INC | Lloyd-Smith Malcolm | Chief Regulatory Off | S - Sale+OE | $105.95 | -21.5K | 18.9K | -53% | -$2.28M |
| M | 2022-02-09 | 2022-02-07+ | NBIX | NEUROCRINE BIOSCIENCES INC | Lloyd-Smith Malcolm | Chief Regulatory Off | S - Sale | $80.48 | -3,382 | 18.7K | -15% | -$272.2K |
| 2021-07-29 | 2021-07-27 | NBIX | NEUROCRINE BIOSCIENCES INC | Lloyd-Smith Malcolm | Chief Regulatory Off | S - Sale | $93.80 | -16.7K | 15.8K | -51% | -$1.57M |
Purchase Sale Sale after option exercise All abbreviations